Strengthening Wuxi Bio ADC Competitiveness… Aiming for subsidiary listing
2023-07-17 02:48:06 Amid competition to preoccupy ADC (antibody drug conjugate), the next-generation food in the field of contract development and manufacturing (CDMO), Wuxi Biologics is aiming to expand its territory through listing of its subsidiary. Wuxi Biologics announced plans to list Wuxi XDC, a subsidiary specializing in bioconjugates such as ADC. According to the pharmaceutical … Read more